Wall Street Zen Upgrades Lakeland Industries (NASDAQ:LAKE) to Hold

Lakeland Industries (NASDAQ:LAKE) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Sunday.

A number of other equities analysts also recently commented on LAKE. Weiss Ratings raised shares of Lakeland Industries from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, June 29th. DA Davidson upped their target price on shares of Lakeland Industries from $14.00 to $18.00 and gave the company a “buy” rating in a research note on Thursday, June 11th. Lake Street Capital dropped their price target on shares of Lakeland Industries from $16.00 to $13.00 and set a “buy” rating for the company in a research report on Friday, April 17th. Finally, Maxim Group set a $16.00 price target on shares of Lakeland Industries in a research note on Monday, April 20th. Three investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $16.00.

Lakeland Industries Stock Performance

Shares of NASDAQ LAKE traded down $0.07 during trading hours on Friday, reaching $11.03. The stock had a trading volume of 83,161 shares, compared to its average volume of 156,373. The company has a market cap of $108.87 million, a price-to-earnings ratio of -5.18 and a beta of 1.45. Lakeland Industries has a twelve month low of $7.15 and a twelve month high of $18.00. The business’s fifty day moving average is $10.56 and its two-hundred day moving average is $9.62. The company has a debt-to-equity ratio of 0.20, a current ratio of 3.09 and a quick ratio of 1.34.

Lakeland Industries (NASDAQ:LAKE) last posted its quarterly earnings results on Tuesday, June 9th. The medical instruments supplier reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.18. The firm had revenue of $47.42 million for the quarter, compared to the consensus estimate of $47.36 million. Lakeland Industries had a negative net margin of 10.87% and a negative return on equity of 6.64%. As a group, research analysts expect that Lakeland Industries will post -0.28 EPS for the current year.

Institutional Trading of Lakeland Industries

Several hedge funds have recently modified their holdings of LAKE. Private Capital Management LLC boosted its holdings in shares of Lakeland Industries by 2.8% in the 4th quarter. Private Capital Management LLC now owns 1,202,433 shares of the medical instruments supplier’s stock worth $10,630,000 after acquiring an additional 32,945 shares in the last quarter. Pacific Ridge Capital Partners LLC increased its holdings in Lakeland Industries by 62.3% during the 4th quarter. Pacific Ridge Capital Partners LLC now owns 772,015 shares of the medical instruments supplier’s stock valued at $6,825,000 after purchasing an additional 296,222 shares in the last quarter. Vanguard Group Inc. increased its holdings in Lakeland Industries by 2.3% during the 3rd quarter. Vanguard Group Inc. now owns 486,524 shares of the medical instruments supplier’s stock valued at $7,201,000 after purchasing an additional 10,764 shares in the last quarter. Geode Capital Management LLC raised its position in Lakeland Industries by 115.9% in the 2nd quarter. Geode Capital Management LLC now owns 217,786 shares of the medical instruments supplier’s stock valued at $2,964,000 after purchasing an additional 116,901 shares during the last quarter. Finally, Crawford Investment Counsel Inc. raised its position in Lakeland Industries by 13.9% in the 3rd quarter. Crawford Investment Counsel Inc. now owns 208,398 shares of the medical instruments supplier’s stock valued at $3,084,000 after purchasing an additional 25,429 shares during the last quarter. Institutional investors and hedge funds own 71.69% of the company’s stock.

About Lakeland Industries

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.